- DKK16.77bn
- DKK16.63bn
- DKK6.04bn
Ambu shares fall after Q1 net profit, FCF miss
Brief: Ambu Q1 EBIT Before Special Items Widens To DKK 243 Mln
Ambu tops STOXX on outlook hike, strong Q1 prelims
Brief: Ambu Raises Outlook For 2024/25
Top of the Street: Shell, Repsol, Ambu, SSE, DSM-Firmenich
Carnegie ups Ambu to 'buy' after recent selloff
JPM sees challenges to continue for European medtech & services in H1
Ambu slumps to bottom of STOXX on Q4 organic growth, EBIT misses
Brief: Ambu Launches HD Cystoscopy Solution In US
Europe Research Roundup: Carnival, Kingfisher, Unite Group
Ambu slumps as Endoscopy segment lags expectations
Brief: Ambu Q3 Adjusted EBIT DKK 178 Million Vs. Estimate DKK 178 Million
Ambu jumps after it hikes outlook, reports Q3 beat
Brief: Ambu Q3 Revenue DKK 1,383 Million
JPM ups Ambu on balanced risks, improving business profile
Europe Research Roundup: ABB Ltd, Capital & Regional Plc, Neste Oyj
Brief: Ambu Maintains Adjusted FY 2023/24 Financial Guidance
Brief: Ambu Q2 Adjusted EBIT DKK 194 Million Vs. Estimate DKK 194 Million
Brief: Ambu Gets FDA Clearance For Generation Duodenoscopy Solution